As the C language, which forms the basis of critical global software like operating systems, faces security limitations, ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Labor markets in Central America and the Dominican Republic face limited direct impacts from technological advancements ...

As the C language, which forms the basis of critical global software like operating systems, faces security limitations, ...

The Los Angeles Business Journal and PNC Bank proudly announce our new podcast series: PNC C-Speak®, the Language of Executives, a podcast created to amplify the forward-thinking business approaches ...

Effective monitoring of development aid is the foundation for assessing the alignment of flows with their intended ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

SALT LAKE CITY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...

With AI advancements upending the role of senior executives, the question is what the C-suite transformation should look like ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Recursion Pharmaceuticals ( ($RXRX) ) has provided an update. Recursion Pharmaceuticals announced significant leadership changes effective January ...

Recursion Pharmaceuticals, Inc (($RXRX)) has held its Q3 earnings call. Read on for the main highlights of the call. Recursion Pharmaceuticals, ...